GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.45 $5.86 Thursday, 18th Apr 2024 BCRX stock ended at $4.50. This is 1.75% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $4.49 to a day high of $4.71.
90 days $4.45 $6.35
52 weeks $4.45 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
2023-05-25 $8.21 $8.21 $7.91 $7.99 2 323 997
2023-05-24 $8.78 $8.78 $8.15 $8.22 3 000 739
2023-05-23 $8.59 $8.92 $8.57 $8.77 3 198 009
2023-05-22 $8.43 $8.62 $8.43 $8.57 2 576 675
2023-05-19 $8.48 $8.51 $8.33 $8.44 2 045 682
2023-05-18 $8.49 $8.49 $8.27 $8.37 2 031 948
2023-05-17 $8.48 $8.66 $8.41 $8.47 2 801 290
2023-05-16 $8.55 $8.55 $8.37 $8.46 2 254 687
2023-05-15 $8.36 $8.91 $8.31 $8.77 2 345 284
2023-05-12 $8.37 $8.45 $8.25 $8.30 1 832 877
2023-05-11 $8.56 $8.59 $8.35 $8.36 2 020 307
2023-05-10 $8.66 $8.82 $8.57 $8.63 1 539 373
2023-05-09 $8.41 $8.66 $8.39 $8.58 2 223 858
2023-05-08 $8.54 $8.62 $8.42 $8.49 2 588 407
2023-05-05 $8.52 $8.62 $8.21 $8.56 3 163 512
2023-05-04 $8.35 $8.52 $8.00 $8.47 3 126 234
2023-05-03 $8.13 $9.07 $8.00 $8.29 7 327 166
2023-05-02 $7.50 $7.55 $7.28 $7.37 3 328 437
2023-05-01 $7.59 $7.63 $7.45 $7.51 2 846 473
2023-04-28 $7.49 $7.67 $7.48 $7.61 1 845 637
2023-04-27 $7.72 $7.75 $7.45 $7.53 1 912 096
2023-04-26 $7.48 $7.69 $7.42 $7.62 1 942 228
2023-04-25 $7.58 $7.58 $7.41 $7.49 2 062 315
2023-04-24 $7.51 $7.61 $7.36 $7.61 2 772 736
2023-04-21 $7.40 $7.55 $7.27 $7.52 2 594 852
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT